B

Benepharma

BE0685.992.809

Gross margin
€ 472K ↑ 11% 2025 Total € 2.45M
Profit
€ 162K ↑ 19% 2025 Total € 679K
EBITDA
€ 318K ↑ 16% 2025 Total € 1.40M
EBIT
€ 243K ↑ 20% 2025 Total € 839K
Net profit
€ 162K ↑ 19% 2025 Total € 679K
Capex
€ 20K ↓ 27% 2025 Total € 498K
Assets
€ 814K ↓ 7% 2025
Equity
€ 459K ↓ 9% 2025
Debt
€ 355K ↓ 4% 2025
Cash
€ 138K ↓ 18% 2025
Cashflow
€ 237K ↑ 14% 2025 Total € 1.23M
Working capital
€ 275K ↓ 2% 2025
Current ratio
2.68 ↓ 6% 2025
Quick ratio
1.59 ↓ 11% 2025
Working capital ratio
2.73 ↓ 6% 2025
Debt
€ 355K ↓ 4% 2025
Short-term debt
€ 160K ↑ 8% 2025
Long-term debt
€ 191K ↓ 13% 2025
Debt / EBITDA
1.12 ↓ 17% 2025
Solvability
56.4% ↓ 1.2 pt 2025
Long term debt ratio
0.42 ↓ 5% 2025
Gross profitability
51.5% ↑ 10.3 pt 2025
Net profitability
35.2% ↑ 8.4 pt 2025
Return On Assets (ROA)
19.86 ↑ 28% 2025
Return On Equity (ROE)
35.22 ↑ 31% 2025
Taxes
€ 24K ↑ 443% 2025 Total € 135K
Salaries and Social Security Contributions
€ 21K ↑ 1% 2025 Total € 137K
Employees
2.30 ↓ 8% 2025
Staff cost per employee
€ 9K ↑ 10% 2025
Dividends
€ 207K ↑ 730% 2025 Total € 232K
Dividend payout
128.3% ↑ 109.8 pt 2025